Eledon Pharmaceuticals, Inc.ELDNNASDAQ
LOADING
|||
Operating Income Growth Under Pressure
Trending lower, below historical average, slight contraction.
Left:
||||
Year-over-year operating income growth rate
Latest
-64.13%
↓ 137% below average
Average (9y)
-27.09%
Historical baseline
Range
High:65.58%
Low:-177.55%
CAGR
-4.0%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | -64.13% |
| 2023 | -8.09% |
| 2022 | -7.90% |
| 2021 | -177.55% |
| 2020 | 6.35% |
| 2019 | -0.88% |
| 2018 | -7.16% |
| 2017 | 65.58% |
| 2016 | 15.77% |
| 2015 | -92.91% |